These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25027708)

  • 21. Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies.
    Batra G; Raut R; Dahiya S; Kamran N; Swaminathan S; Khanna N
    J Virol Methods; 2010 Jul; 167(1):10-6. PubMed ID: 20211204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single antigen detects both immunoglobulin M (IgM) and IgG antibodies elicited by all four dengue virus serotypes.
    Hapugoda MD; Batra G; Abeyewickreme W; Swaminathan S; Khanna N
    Clin Vaccine Immunol; 2007 Nov; 14(11):1505-14. PubMed ID: 17898184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dengue-1 envelope protein domain III produced in Pichia pastoris: potential use for serological diagnosis.
    Cardoso SA; Paixão VF; Oliveira MD; Honda ER; Oliveira LL; da Silva CC; De Paula SO
    Protein Expr Purif; 2013 Nov; 92(1):9-13. PubMed ID: 23993978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characterization and secreted expression of dengue virus type I-IV envelope glycoprotein domain III in Pichia pastoris].
    Cai JP; Qian F; Wang JY; Zhao Y; Xu XJ; Jin WR; Che XY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Aug; 44(8):721-5. PubMed ID: 21055023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes.
    Khanam S; Rajendra P; Khanna N; Swaminathan S
    BMC Biotechnol; 2007 Feb; 7():10. PubMed ID: 17302980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of tetravalent protective immunity against four dengue serotypes by the tandem domain III of the envelope protein.
    Chen S; Yu M; Jiang T; Deng Y; Qin C; Qin E
    DNA Cell Biol; 2007 Jun; 26(6):361-7. PubMed ID: 17570760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of tetravalent dengue virus envelope protein domain III based antigens in lettuce chloroplasts and immunologic analysis for future oral vaccine development.
    van Eerde A; Gottschamel J; Bock R; Hansen KEA; Munang'andu HM; Daniell H; Liu Clarke J
    Plant Biotechnol J; 2019 Jul; 17(7):1408-1417. PubMed ID: 30578710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of disulfide bridging to epitope expression of the dengue type 2 virus envelope glycoprotein.
    Roehrig JT; Volpe KE; Squires J; Hunt AR; Davis BS; Chang GJ
    J Virol; 2004 Mar; 78(5):2648-52. PubMed ID: 14963174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses.
    Brandler S; Ruffie C; Najburg V; Frenkiel MP; Bedouelle H; Desprès P; Tangy F
    Vaccine; 2010 Sep; 28(41):6730-9. PubMed ID: 20688034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting of envelope domain III protein of DENV type 2 to DEC-205 receptor elicits neutralizing antibodies in mice.
    Coconi-Linares N; Ortega-Dávila E; López-González M; García-Machorro J; García-Cordero J; Steinman RM; Cedillo-Barrón L; Gómez-Lim MA
    Vaccine; 2013 May; 31(19):2366-71. PubMed ID: 23499580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli.
    Yang J; Zhang J; Chen W; Hu Z; Zhu J; Fang X; Yuan W; Li M; Hu X; Tan Y; Hu F; Rao X
    Can J Microbiol; 2012 Apr; 58(4):369-80. PubMed ID: 22420529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of mucosal vaccines to Peyer's patch M cells.
    Frey A; Neutra MR
    Behring Inst Mitt; 1997 Feb; (98):376-89. PubMed ID: 9382762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.
    Brayden DJ; Jepson MA; Baird AW
    Drug Discov Today; 2005 Sep; 10(17):1145-57. PubMed ID: 16182207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate.
    Bal J; Luong NN; Park J; Song KD; Jang YS; Kim DH
    Microb Cell Fact; 2018 Feb; 17(1):24. PubMed ID: 29452594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C5a receptor targeting of partial non-structural protein 3 of dengue virus promotes antigen-specific IFN-γ-producing T-cell responses in a mucosal dengue vaccine model.
    Kim SH; Kim YN; Kim J; Jang YS
    Cell Immunol; 2018 Mar; 325():41-47. PubMed ID: 29397905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques.
    Raviprakash K; Apt D; Brinkman A; Skinner C; Yang S; Dawes G; Ewing D; Wu SJ; Bass S; Punnonen J; Porter K
    Virology; 2006 Sep; 353(1):166-73. PubMed ID: 16814355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a peptide enhancing mucosal and systemic immune responses against EGFP after oral administration in mice.
    Kim SH; Lee KY; Kim J; Park SM; Park BK; Jang YS
    Mol Cells; 2006 Apr; 21(2):244-50. PubMed ID: 16682820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines.
    Kim SH; Jang YS
    Exp Mol Med; 2014 Mar; 46(3):e85. PubMed ID: 24626171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of an immunocomplex consisting of Fc fragment fused with a consensus dengue envelope domain III in Saccharomyces cerevisiae.
    So KK; Chun J; Luong NN; Seo HW; Kim DH
    Biotechnol Lett; 2021 Sep; 43(9):1895-1904. PubMed ID: 34245387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards targeting strategies for oral immunization--identification of marker antigens in rat M cells.
    Rautenberg K; Cichon C; Schmidt MA
    Behring Inst Mitt; 1997 Feb; (98):361-75. PubMed ID: 9382761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.